|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 401/12 | |
| A61K 31/4709 | |||
| A61P 35/00 |
| (11) | Patento numeris | 3231797 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15867543.9 |
| Europos patento paraiškos padavimo data | 2015-12-09 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-10-18 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-02-26 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/CN2015/096777 |
| Data | 2015-12-09 |
| (87) | Numeris | WO 2016/091168 |
| Data | 2016-06-16 |
| (30) | Numeris | Data | Šalis |
| 201410749394 | 2014-12-09 | CN |
| (72) |
WANG, Xunqiang, CN
MIAO, Yadong, CN
ZHOU, Min, CN
WANG, Shanchun, CN
YANG, Ling, CN
SHI, Wei, CN
|
| (73) |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.,
No. 369 Yuzhou South Road Haizhou District Lianyungang, Jiangsu 222062,
CN
Advenchen Laboratories Nanjing Ltd., Room 302, Block A, Pharmaceutical & Biology Incubator Building Entrepreneurship Center Nanjing New & High Tech Zone, Nanjing, Jiangsu 210061, CN |
| (54) | QUINOLINE DERIVATIVE AGAINST NON-SMALL CELL LUNG CANCER |
| QUINOLINE DERIVATIVE AGAINST NON-SMALL CELL LUNG CANCER |